SELLAS Life Sciences Group, Inc. (SLS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -8.85M | -4.92M | -7.07M | -7.33M | -9.07M | -7.15M | -7.81M | -9.68M | -10.76M | -4.83M | -6.89M | -7.57M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 2.47% | 31.2% | 9.45% | 24.29% | 15.71% | -48.25% | -13.26% | -27.97% | 11.26% | 6.35% | -19.94% | -31.33% |
| Net Income | -8.41M | -7.66M | -6.79M | -6.6M | -5.81M | -6.74M | -7.11M | -7.47M | -9.57M | -8.14M | -9.27M | -8.84M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 158K |
| Stock-Based Compensation | 0 | 447K | 503K | 501K | 505K | 373K | 381K | 334K | 476K | 497K | 543K | 514K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -158K |
| Other Non-Cash Items | 951K | 154K | 147K | 149K | 147K | 148K | 137K | -921K | 138K | 128K | 122K | 156K |
| Working Capital Changes | -1.39M | 2.14M | -927K | -1.38M | -3.91M | -937K | -1.22M | -1.63M | -1.81M | 2.69M | 1.71M | 604K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 685K | 660K | -1.03M | -441K | 277K | -1.12M | -1.77M | -1.06M | 1.81M | 1.32M | 606K | 661K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3M | -2.5M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.5M | -3M | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.5M | 0 | -2.5M |
| Cash from Financing | 44.15M | 32.39M | 26.09M | 4.23M | 23.58M | 8K | 19.69M | 414K | 26.65M | 3.39M | 54K | -29K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 44.15M | 32.92M | 26.09M | 4.23M | 23.58M | 71K | 19.49M | 59K | 26.55M | 3.4M | 54K | -29K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -527K | 0 | 0 | 0 | -63K | 202K | 355K | 100K | -17K | 0 | 0 |
| Net Change in Cash | 35.3M | 27.47M | 19.02M | -3.1M | 14.51M | -7.14M | 11.88M | -9.27M | 15.88M | -1.44M | -9.84M | -10.1M |
| Free Cash Flow | -8.85M | -4.92M | -7.07M | -7.33M | -9.07M | -7.15M | -7.81M | -9.68M | -10.76M | -10.32M | -9.89M | -7.57M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 2.47% | 31.2% | 9.45% | 24.29% | 15.71% | 30.72% | 21.09% | -27.97% | 11.26% | -6.97% | -72.15% | -31.33% |
| FCF per Share | -0.05 | -0.03 | -0.07 | -0.07 | -0.10 | -0.10 | -0.11 | -0.17 | -0.24 | -0.34 | -0.35 | -0.27 |
| FCF Conversion (FCF/Net Income) | 1.05x | 0.64x | 1.04x | 1.11x | 1.56x | 1.06x | 1.10x | 1.30x | 1.12x | 0.59x | 0.74x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |